Indices closed down.
S&P 500 @ 2063.37, low 2054.89, high 2077.18
RSI @ 48.93
CMF @ 0.172
Internals were :
Down volume led by 6.02 to 1 in NYSE & 2.96 to 1 in Nasdaq
Declining stocks led by 3.09 to 1 in NYSE & 2.82 to 1 in Nasdaq
Net new 52 wk highs were leading by 75 in NYSE & lows by 12 in Nasdaq
VIX UP 6.27% @ 15.60
Oil @ $43.65
Gold @ $1291.80
AH ER...ZG UP 13.92%, RUBI Down 8.02%
AH Futures UP
AH Asian Markets Down
AH Oil UP
AH Gold Down
About market, TAPE faced many negatives out of China, Europe and USA, considering everything which was thrown @ this TAPE, we closed well above lows, which is a victory. These sharp selling is actually very healthy as it flushes out euphoria and complacency in a hurry. CMF actually improved in S&P 500, which is remarkable. This TAPE is known for resiliency and it got displayed in a big way today. May, may be the month where we make a new all time highs, stay tuned.
BLOG does NOT give buy or sell.
Saleem
2 comments:
Hi Stocktrader,
Thanks for your input on RLYP. The market is so crazy. I agree it can go to 10 or 40. There is a debate going on regarding the debt (message board). I have traded the stock quite sometime and made some profit. Hope things will turn around.
Good Luck
Joseph
Hi Joseph,
The only reason it could go to $10 is if it really decides to go alone for the next 12+ months as Mizuho has suggested this morning (while lowering rating to Underperform and target to $12 from $22).
Honestly, I think that is a ludicrous read on this situation. The company is designed as a takeover, and the economies of scale that a larger drug company and sales force would have with RLYP's drug makes it much more valuable than the current stock price suggests...and all parties know this, including RLYP. The nature of the loan removes the major financing overhang with almost no dilution (small amount of warrants issued), which will give them extra leverage in the buyout talks. I think they are waiting for the competitor's PDUFA and they will sell within short order afterwards, regardless of that outcome, but certainly extremely meaningful when it comes to price. I give this company 3 months maximum as a standalone.
On another note, I think there is a chance they lower their OpEx guidance tonight from the extremely aggressive spending projections given last quarter. That could provide a minor boost. The sales numbers are basically all known, and are still rather tepid for now.
Stocktrader
Post a Comment